We thus hypothesized that the loss of normal PSEN2 function would alter the anticonvulsant activity profile of mechanistically distinct ASMs in this preclinical seizure model and establish the differentiation capacity of the 6-Hz seizure test evoked in PSEN2-KO mice as a suitable strategy for ASM discovery for seizures in AD. The gene discussed is PSEN2; the disease is Alzheimer disease.